A B S T R A C T Activities of mitochondrial enzymes in blood cells from 69 patients with primary sideroblastic anemia were determined to elucidate the pathogenesis ofthe disease. In erythroblasts of patients with primary acquired type the activities of both 8-aminolevulinic acid synthetase and mitochondrial serine protease were inevitably decreased. The susceptibility to the protease of apo-8-aminolevulinic acid synthetase prepared from erythroblasts of patients with this type was within the normal range, in contrast to that of pyridoxineresponsive anemia. The activities of mitochondrial enzymes such as cytochrome oxidase, serine protease, and oligomycin-sensitive ATPase, except citrate synthetase, were usually decreased in mature granulocytes of the patients. Patients with hereditary sideroblastic anemia also had decreased 8-aminolevulinic acid synthetase activity in erythroblasts, and decreased serine protease activity in both erythroblasts and mature granulocytes. Mature granulocytes obtained from patients with pyridoxine-responsive anemia before therapy had decreased cytochrome oxidase activity, however, the activity increased to a normal level when the patients were in remission. The activities of other mitochondrial enzymes in mature granulocytes were within normal range in these patients before pyridoxine therapy. The activities of these mitochondrial enzymes in lymphocytes were within normal range in all groups of patients with primary sideroblastic anemia.
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We suggest that patients with primary acquired, and possibly also those with hereditary sideroblastic anemia have impaired mitochondrial function in both erythroblasts and granulocytes. That only anemia is observed in these patients is because a functional abnomiality of mitochondria in erythroblasts is most important because of the role of mitochondria in the fomiation of heme in erythrocyte development. In con-
INTRODUCTION
Patients with primary sideroblastic anemia show hypochromic or dimorphic anemia, elevated serum iron with high saturation of total iron binding capacity, and erythroid hyperplasia in the bone marrow with the presence of a large number of ring sideroblasts. Ferrokinetic studies usually show accelerated plasma iron disappearance with impaired iron incorporation into erythrocytes. Almost all features characteristic ofthis disease can be ascribed to a disturbance of heme synthesis in erythroblasts (1, 2) . In fact, the activity of 8-aminolevulinic acid (ALA)' synthetase, the rate-limiting enzyme in heme synthesis is inevitably decreased in erythroblasts of patients with primary sideroblastic anemia (2) .
In the course ofinvestigation ofthe regulation ofALA synthetase activity in erythroblasts, a new serine protease was found on the inner mitochondrial membrane of bone marrow cells including both erythroblasts and granulocytes (3). An inverse relationship was observed between ALA synthetase activity and this serine protease activity in erythroblasts (3) . Therefore, the protease activity in erythroblasts of patients with primary sideroblastic anemia was measured. Unexpectedly, not only ALA synthetase activity but also the serine protease activity was inevitably decreased in erythroblasts of patients with primary acquired sideroblastic anemia. Also the protease activity in mature granulocytes obtained from patients with primary acquired sideroblastic anemia was decreased.
In this paper we studied several mitochondrial en-zyme activities in erythroblasts, granulocytes, and lymphocytes obtained from patients with primary sideroblastic anemia. We found that multiple enzymatic defects in mitochondria in both erythroblasts and granulocytes are characteristic to primary acquired sideroblastic anemia and possibly to hereditary sideroblastic anemia. On the other hand, only ALA synthetase in both erythroblasts and granulocytes seems to be impaired in patients with pyridoxine-responsive anemia.
METHODS
Patients. 61 cases with primary acquired sideroblastic anemia, 6 cases with hereditary sideroblastic anemia, and 2 cases with pyridoxine-responsive anemia were employed in this report. Samples from these patients were collected from 34 hospitals in various parts of Japan between June 1972 and September 1979. These patients were diagnosed on the basis of hypochromic or dimorphic anemia, hyperferremia with increased saturation ofiron binding capacity, erythroid hyperplasia in the bone marrow, the presence of a large number of ring sideroblasts (above 30%), and the absence of causative diseases such as leukemia, chronic inflammation, or malignancy. Diagnosis of six cases with hereditary sideroblastic anemia was based on family history, male sex, and early occurrence of anemia. Every patient with these two types of sideroblastic anemia was treated unsuccessfully with pharmacological doses of pyridoxine. Two patients with pyridoxineresponsive anemia (classical form) have been described (4) .
Cell separation. The erythroblast-rich fraction was prepared from aspirated bone marrow cells as described (4) . Cellular components of bone marrow aspirate that were suspended in 20 ml of saline were filtered through four layers of gauze, and the filtrate was layered on a separating medium consisting of two parts (10 ml Midland, Mich.) 50 x 8 W column chromatography to be counted by a liquid scintillation counter as described (2). 1 U was defined as the enzyme activity producing 1 nmol of ALA in 30 min under the conditions described (2) .
The assay of the protease activity was performed as described (4). Blood cells (5 x 106_1 x 107) suspended in 3 ml of0.85% NaCl containing 0.01 M potassium phosphate buffer, pH 7.5, were sonicated at 50 W for 15 s in a 50-ml centrifuge tube (Branson Sonic Power Co. Danbury, Conn.; model W 185), and then centrifuged at 20,000 g for 15 min. From the precipitate, the protease was extracted with 1 ml of 0.5 M potassium phosphate buffer, pH 7.0, for 30 min at 37°C, and the activity was measured using apo-ornithine transaminase as substrate (3, 4) . 1 U was defined as the amount of protease inactivating 50% of apo-ornithine transaminase in 30 min under the conditions described (3, 4) .
Cytochrome oxidase activity was measured by the method of Smith (5) . Blood cells (5-8 x 106) suspended in 1 ml of saline were sonicated at 50 W for 15 s in a 10-ml centrifuge tube to be used as the enzyme solution. Reaction mixtures contained reduced cytochrome c, 90 nmol; potassium phosphate buffer, pH 6.0, 225 imol; and enzyme solution, 0.2 ml in a final vol of 3 ml. The control tube contained 1 mM potassium cyanide in addition to the above components. Reactions were started by adding the enzyme solution, and initial reaction rates were determined by measuring continuously the decrease of absorbance at 550 nm at 25°C. 1 U was defined as the enzyme activity oxidizing 1 ,umol reduced cytochrome c/min under the conditions described above.
The reaction was linear up to 3 x 106 of blood cells/3 ml of incubation mixture, and the difference in duplicate analysis was always within 10%.
Oligomycin-sensitive ATPase activity was measured by the method of Kagawa (6) . The enzyme solution was prepared by sonicating cells (1-1.5 x 107) suspended in 1 ml of 0.85% NaCl that contained 50 mM Tris-HCl (pH 7.5) and 10 mM MgCl2 at 50 W for 15 s in a 10-ml centrifuge tube. Reaction mixtures contained ATP, 3 ,umol; MgCl2, 1.5 Fig. 1 .
Protease activity. The protease activity assayed by 10[ the method described above is considered to indicate the activity of the new serine protease described (3, 4) from the following reasons. Firstly, the activity assayed by this method was completely inhibited by the addition of a small amount of elastatinal (100 ,.g/ml), the inhibitor of both pancreas elastase and this protease (3, 9) . Secondly, the enzyme solution used in these experiments showed no detectable elastolytic activity. Thirdly, elastase from swine pancreas (Worthington Biochemical Corp., Freehold, N. J.) exhibited a poor ability to inactivate apo-ornithine transaminase as compared with that of this new protease (17% of the protease).
Because the erythroblast-rich fraction contained a small number of immature granulocytes and lymphocytes, the protease activity in erythroblasts was calculated considering relative contribution of different cell populations to the protease activity as described (4) . In contrast to the normal protease activity in erythroblasts of patients with pyridoxine-responsive anemia, erythroblasts obtained from 18 cases with primary acquired sideroblastic anemia and those from three cases with hereditary sideroblastic anemia had decreased protease activity as shown in Fig. 2 .
The protease activity in mature granulocytes from patients with primary sideroblastic anemia is shown in Fig. 3 . All except three cases with primary acquired sideroblastic anemia had decreased protease activity in mature granulocytes. Mature also showed decreased protease activity. On the contrary, mature granulocytes obtained from two cases with pyridoxine-responsive anemia before therapy revealed the protease activity within normiial range. Itnactivationi of apo-ALA sytithetase by the protease. Degrees of inactivation of the apo-ALA synthetase by the protease that is considered to be engaged in the regulation of ALA synthetase levels in mitochondria in erythroblasts were examined by the method described (4) . Results are shown in Table I . In contrast to the apo-ALA synthetase prepared from erythroblasts of patients with pyridoxine-responsive anemia, degrees of inactivation by the protease of apo-ALA synthetase prepared from patients with primary acquired sideroblastic anemia were almost the same as those of normal controls.
Cytochrome oxidase activity. Both mature granulocytes and lymphocytes in the peripheral blood were employed for the determination of cytochrome oxidase activity. Addition of catalase (10 nM) from bovine liver (Boehringer Mannheim GmbH) to the reaction mixture had no effect on the oxidation of cytochromie c by the enzyme solution, therefore, cytochrome c peroxidase does not play any roles in the oxidation of cytochrome c by the reaction system employed here. Furthermore, the reaction mixture containing 1 mM potassium cyanide showed only a little oxidation of reduced cytochrome c, and that with 1 mnM potassiuimi cyanide containing oxidized cytochromne c instead of the reduced form revealed no significant reduction of cvtochromiie c as judged by the changes in the absorbance at 550 nm. These results indicate that the decrease in absorbance at 550 nm under the conditions described in the Methods shows the activity of cytochrome oxidase. Fig. 4 shows the cvtochrome oxidase activity in both mature granulocytes and lymphocytes obtained from patients with primary sideroblastic aniemia. Every case with primary acq(Iuired sideroblastic anemiiia had decreased cytochrome oxidase activity in mature granulocytes. Also mature granulocytes obtained from two cases with pyridoxine-responsive anemia before treatmenit showed decreasedl activity, however, the activity increased to the normiial level when the patients went into remission after treatment with pharmacological doses of pyridoxal phosphate (Fig. 4) Primary sideroblastic anemia can be classified into locytes and three types; primary acquired, hereditary, and pyriained from doxine-responsive. Besides these primary sideroblastic and those anemias, secondary types such as those induced by es contain-drugs or alcohol, and those accompanying various ium malate diseases are recognized. Among primary sideroblastic of NADH anemias the most frequent type is the primary acquired absorbance type. Almost all the symptoms of this disorder can be ase activity ascribed to the impaired heme synthesis resulting from bytes of the the decreased ALA synthetase activity in erythroblasts observed, (1, 2) . In fact, every patient with primary sideroblastic re granulo-anemia, including that with primary acquired type, tients with had decreased ALA synthetase activity in erythroblasts hin normal as shown in Fig. 1 . The decrease of this enzyme ranulocytes activity in erythroblasts of the patients is considered tients with not to be secondary to iron deposition in mitochondria the normal but to be the primary defect in erythroblasts (1, 2) .
Recently, we found a new serine protease in mitothe treat-chondria in both erythroblasts and granulocytes (3) . indria were The protease in erythroblasts is considered to be enMitochondrial Defects in Blood Cells in Sideroblastic Anemia gaged in the regulation of ALA synthetas mitochondria. However, protease activity i in erythroblasts of patients with primal sideroblastic anemia. Furthermore, the resi susceptibility to the protease of apo-ALA prepared from erythroblasts of patients w acquired sideroblastic anemia was within n in contrast to that prepared from pyridoxine anemia suggest that the cause of the decre synthetase activity in erythroblasts differs i types of sideroblastic anemia. Besides the characteristic anemia that is sion of the abnormality in erythropoietic tients with primary acquired sideroblastic a develop a decreased number of granuloc peripheral blood (10, 11) . In our series the the patients with primary acquired type creased numbers of granulocytes in the blood. As shown in Fig. 3 (13) . Impaired synthesis of DNA se levels in and RNA, and depression of protein synthesis in s decreased erythroblasts of patients with primary acquired siderory acquired blastic anemia was reported by Wickramasinghe and ults that the Hughes (14) . They showed that ring sideroblasts at synthetase an immature stage exhibited almost normal synthesis 'ith primary of both nucleic acids and proteins, while at a more Lormal range mature stage the synthesis of both nucleic acids and -responsive protein was diminished. Therefore, the disturbances ase of ALA of both nucleic acid synthesis and protein synthesis in in these two ring sideroblasts may stem from the mitochondrial lesions. We speculate that defects in mitochondria the expres-in both erythroblasts and granulocytes are the etiology series, pa-of primary acquired sideroblastic anemia.
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